Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
CNY 5.68
(1.25%)
CNY 5.68
(1.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 181.86 Million CNY | -43.77% |
| 2022 | 323.41 Million CNY | 78.6% |
| 2021 | 181.07 Million CNY | 222.66% |
| 2020 | -147.62 Million CNY | -156.23% |
| 2019 | 262.56 Million CNY | 18.62% |
| 2018 | 221.34 Million CNY | 20.95% |
| 2017 | 183 Million CNY | -18.47% |
| 2016 | 224.46 Million CNY | -15.98% |
| 2015 | 267.15 Million CNY | 9.02% |
| 2014 | 245.03 Million CNY | 31.02% |
| 2013 | 187.02 Million CNY | 15.59% |
| 2012 | 161.8 Million CNY | 6.28% |
| 2011 | 152.24 Million CNY | 1.14% |
| 2010 | 150.52 Million CNY | 19.76% |
| 2009 | 125.69 Million CNY | 38.98% |
| 2008 | 90.43 Million CNY | 98.22% |
| 2007 | 45.62 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 104.1 Million CNY | 750.91% |
| 2024 Q3 | 126.79 Million CNY | 61.14% |
| 2024 Q2 | 78.68 Million CNY | -24.42% |
| 2023 FY | 181.86 Million CNY | -43.77% |
| 2023 Q2 | 33.07 Million CNY | -61.51% |
| 2023 Q1 | 85.94 Million CNY | 56.22% |
| 2023 Q4 | -15.99 Million CNY | -120.29% |
| 2023 Q3 | 78.82 Million CNY | 138.31% |
| 2022 FY | 323.41 Million CNY | 78.6% |
| 2022 Q3 | 66.54 Million CNY | -9.6% |
| 2022 Q2 | 73.6 Million CNY | -42.6% |
| 2022 Q1 | 128.24 Million CNY | 1550.33% |
| 2022 Q4 | 55.01 Million CNY | -17.32% |
| 2021 Q4 | -8.84 Million CNY | -108.77% |
| 2021 Q1 | 54.35 Million CNY | 119.54% |
| 2021 Q3 | 100.77 Million CNY | 189.65% |
| 2021 FY | 181.07 Million CNY | 222.66% |
| 2021 Q2 | 34.79 Million CNY | -36.0% |
| 2020 Q4 | -278.22 Million CNY | -437.24% |
| 2020 Q3 | 82.5 Million CNY | -7.37% |
| 2020 Q2 | 89.06 Million CNY | 451.27% |
| 2020 FY | -147.62 Million CNY | -156.23% |
| 2020 Q1 | -25.35 Million CNY | -161.13% |
| 2019 Q1 | 89.36 Million CNY | 742.66% |
| 2019 FY | 262.56 Million CNY | 18.62% |
| 2019 Q4 | 41.47 Million CNY | -10.31% |
| 2019 Q3 | 46.24 Million CNY | -45.89% |
| 2019 Q2 | 85.47 Million CNY | -4.36% |
| 2018 Q1 | 84.07 Million CNY | 623.04% |
| 2018 FY | 221.34 Million CNY | 20.95% |
| 2018 Q4 | 10.6 Million CNY | -77.57% |
| 2018 Q3 | 47.29 Million CNY | -40.42% |
| 2018 Q2 | 79.37 Million CNY | -5.59% |
| 2017 Q3 | 27.37 Million CNY | -62.79% |
| 2017 Q1 | 70.41 Million CNY | 74.36% |
| 2017 FY | 183 Million CNY | -18.47% |
| 2017 Q2 | 73.58 Million CNY | 4.5% |
| 2017 Q4 | 11.62 Million CNY | -57.53% |
| 2016 FY | 224.46 Million CNY | -15.98% |
| 2016 Q1 | 70.24 Million CNY | 6.72% |
| 2016 Q3 | 41.22 Million CNY | -43.22% |
| 2016 Q2 | 72.6 Million CNY | 3.36% |
| 2016 Q4 | 40.38 Million CNY | -2.03% |
| 2015 Q2 | 72.43 Million CNY | 19.33% |
| 2015 FY | 267.15 Million CNY | 9.02% |
| 2015 Q4 | 65.82 Million CNY | -3.47% |
| 2015 Q3 | 68.18 Million CNY | -5.87% |
| 2015 Q1 | 60.7 Million CNY | -8.59% |
| 2014 Q2 | 61.71 Million CNY | 32.19% |
| 2014 Q4 | 66.4 Million CNY | -5.45% |
| 2014 FY | 245.03 Million CNY | 31.02% |
| 2014 Q1 | 46.68 Million CNY | -1.47% |
| 2014 Q3 | 70.23 Million CNY | 13.81% |
| 2013 Q2 | 47.98 Million CNY | 13.56% |
| 2013 Q3 | 49.39 Million CNY | 2.93% |
| 2013 Q4 | 47.38 Million CNY | -4.07% |
| 2013 FY | 187.02 Million CNY | 15.59% |
| 2013 Q1 | 42.25 Million CNY | -12.34% |
| 2012 Q2 | 45.92 Million CNY | 61.45% |
| 2012 Q3 | 39.22 Million CNY | -14.58% |
| 2012 Q1 | 28.44 Million CNY | -29.69% |
| 2012 FY | 161.8 Million CNY | 6.28% |
| 2012 Q4 | 48.2 Million CNY | 22.89% |
| 2011 FY | 152.24 Million CNY | 1.14% |
| 2011 Q2 | 41.65 Million CNY | 12.48% |
| 2011 Q1 | 37.03 Million CNY | -12.78% |
| 2011 Q3 | 33.1 Million CNY | -20.53% |
| 2011 Q4 | 40.45 Million CNY | 22.2% |
| 2010 Q3 | 24.44 Million CNY | -21.79% |
| 2010 Q1 | 52.36 Million CNY | 41.52% |
| 2010 FY | 150.52 Million CNY | 19.76% |
| 2010 Q4 | 42.45 Million CNY | 73.7% |
| 2010 Q2 | 31.25 Million CNY | -40.31% |
| 2009 Q4 | 37 Million CNY | 103.54% |
| 2009 Q3 | 18.17 Million CNY | 0.0% |
| 2009 FY | 125.69 Million CNY | 38.98% |
| 2008 FY | 90.43 Million CNY | 98.22% |
| 2007 FY | 45.62 Million CNY | 0.0% |